All Stories

  1. Brief rapport: Perceptual aberration in patients at ultra‐high risk for psychosis
  2. Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
  3. Fibre density and fibre-bundle cross-section of the corticospinal tract are distinctly linked to psychosis-specific symptoms in antipsychotic-naïve patients with first-episode schizophrenia
  4. A longitudinal study on physiological stress in individuals at ultra high-risk of psychosis
  5. Sleep disturbances and the association with attenuated psychotic symptoms in individuals at ultra high-risk of psychosis
  6. Premorbid functioning in adolescence associates with comorbid disorders in individuals at ultra‐high risk for psychosis: A brief report
  7. Normative modeling of brain morphometry in Clinical High-Risk for Psychosis
  8. White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
  9. Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
  10. Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
  11. Cortico-cognition Coupling in Treatment Resistant Schizophrenia
  12. Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
  13. Changes in negative symptoms are linked to white matter changes in superior longitudinal fasciculus in individuals at ultra-high risk for psychosis
  14. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra‐high risk for psychosis
  15. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis
  16. Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis
  17. Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
  18. Effectiveness of cognitive remediation in the ultra‐high risk state for psychosis
  19. No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
  20. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial
  21. Cerebral Glutamate and Gamma-Aminobutyric Acid Levels in Individuals at Ultra-high Risk for Psychosis and the Association With Clinical Symptoms and Cognition
  22. Experiential negative symptoms are more predictive of real-life functional outcome than expressive negative symptoms in clinical high-risk states
  23. The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends
  24. Predictors of remission from the ultra‐high risk state for psychosis
  25. Assessing social skills in individuals at ultra-high risk for psychosis: Validation of the High Risk Social Challenge task (HiSoC)
  26. Investigating Cognitive and Clinical Predictors of Real-Life Functioning, Functional Capacity, and Quality of Life in Individuals at Ultra-High Risk for Psychosis
  27. Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
  28. Development of Executive Functions as Reflected in Daily Life Behaviors in Young Adults at Ultra-High Risk for Psychosis: Associations With Symptoms and Functioning
  29. Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis
  30. Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
  31. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis
  32. Non-pharmacological modulation of cerebral white matter organization: A systematic review of non-psychiatric and psychiatric studies
  33. T16. GLUTAMATERGIC CHANGES IN UHR
  34. Examining speed of processing of facial emotion recognition in individuals at ultra-high risk for psychosis: Associations with symptoms and cognition
  35. The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
  36. Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis
  37. Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?